Indeed, previous studies have shown increased expression of IL-31 in Th2-dominant diseases such as allergic asthma, atopic dermatitis, and cutaneous T-cell lymphoma, where IL-31 overexpression is associated with Th2 responses25–30. Here, IL31 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.